Literature DB >> 28070668

What happens to asymptomatic lower pole kidney stones smaller than 10 mm in children during watchful waiting?

Onur Telli1, Nurullah Hamidi2, Uygar Bagci2, Arif Demirbas3, Ahmet Metin Hascicek3, Tarkan Soygur4, Berk Burgu4.   

Abstract

BACKGROUND: The optimal management of lower pole kidney (LPK) stones in children is controversial. The aim of this study was to determine the outcomes of children with asymptomatic isolated LPK stones smaller than 10 mm during follow-up.
METHODS: A total of 242 patients with 284 stones presenting at our institution between June 2004 and December 2014 with an asymptomatic, single LPK stone with a diameter of <10 mm were enrolled in the study. All children were assigned to receive first-line therapy and then categorized according to the need for medical intervention. Age, gender, stone laterality, stone size and type, associated urinary tract problems, and uncontrolled metabolic status were assessed as predictive factors of medical treatment for small (<10 mm) asymptomatic LPK stones. Stone-free rates were compared between interventions.
RESULTS: The mean age and mean stone size were 9.4 ± 1.9 years and 7.4 ± 0.6 mm at admission, respectively. Stone progression rate was 61.2%, and the mean time for intervention was 19.2 ± 4.6 months. Flexible ureterorenoscopy (n = 68) or micro-percutaneous nephrolithotomy (n = 4) were performed for 72 stones (25.4%; group 1), and extracorporeal shock wave lithotripsy was performed for 102 stones (35.9%; group 2). The stone-free rates were 81.8 and 79.3% in group 1 and 2, respectively (p > 0.05). The remaining asymptomatic stones (110, 38.8%; group 3) were managed by continued observation, and at the end of the observation time (mean 40.8 ± 20.8 months) the spontaneous passage rate was 9.1% in this group. In the multivariate analysis, stone size of >7 mm, concurrent renal anomalies, and stones composed of magnesium ammonium phosphate (struvite) and cystine were statistically significant predictors of the need for intervention.
CONCLUSIONS: Children with stones larger than 7 mm, renal anomalies, or stones composed of metabolically active cystine or struvite are more likely to require intervention, and those with asymptomatic LPK stones smaller than 10 mm can be managed by continued observation.

Entities:  

Keywords:  Asymptomatic; Children; Kidney; Kidney stones; Lower pole kidney stone

Mesh:

Substances:

Year:  2017        PMID: 28070668     DOI: 10.1007/s00467-016-3570-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

Review 1.  Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment.

Authors:  K Sarica
Journal:  Urol Res       Date:  2006-01-24

Review 2.  Management of stones in patients with anomalously sited kidneys.

Authors:  Andreas J Gross; Megan Fisher
Journal:  Curr Opin Urol       Date:  2006-03       Impact factor: 2.309

3.  The natural history of asymptomatic urolithiasis.

Authors:  L S Glowacki; M L Beecroft; R J Cook; D Pahl; D N Churchill
Journal:  J Urol       Date:  1992-02       Impact factor: 7.450

4.  Etiological and clinical patterns of urolithiasis in Turkish children.

Authors:  A Oner; G Demircin; H Ipekçioğlu; M Bülbül; N Ecin
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

5.  Safety and efficacy of percutaneous nephrolithotomy in infants, preschool age, and older children with different sizes of instruments.

Authors:  Ali Unsal; Berkan Resorlu; Cengiz Kara; Omer Faruk Bozkurt; Ekrem Ozyuvali
Journal:  Urology       Date:  2010-07       Impact factor: 2.649

6.  Outcomes of long-term follow-up of patients with conservative management of asymptomatic renal calculi.

Authors:  Li-Tsa Koh; Foo-Cheong Ng; Kok-Kit Ng
Journal:  BJU Int       Date:  2011-08-18       Impact factor: 5.588

7.  Clinically insignificant residual fragments after percutaneous nephrolithotomy: medium-term follow-up.

Authors:  Fatih Altunrende; Ahmet Tefekli; Robert J Stein; Riccardo Autorino; Emrah Yuruk; Humberto Laydner; Murat Binbay; Ahmet Y Muslumanoglu
Journal:  J Endourol       Date:  2011-05-20       Impact factor: 2.942

8.  Are small residual stone fragments really insignificant in children?

Authors:  Nida Dincel; Berkan Resorlu; Ali Unsal; Abdulkadir Tepeler; Mesrur Selcuk Silay; Abdullah Armağan; Akif Diri; Ahmet Ali Sancaktutar; Tevfik Ziypak; Sevgi Mir
Journal:  J Pediatr Surg       Date:  2013-04       Impact factor: 2.545

9.  Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation.

Authors:  Thomas E Novak; Yegappan Lakshmanan; Bruce J Trock; John P Gearhart; Brian R Matlaga
Journal:  Urology       Date:  2009-05-09       Impact factor: 2.649

10.  Prospective long-term followup of patients with asymptomatic lower pole caliceal stones.

Authors:  Kubilay Inci; Ahmet Sahin; Ekrem Islamoglu; Murat T Eren; Mehmet Bakkaloglu; Haluk Ozen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

View more
  4 in total

Review 1.  Asymptomatic Renal Stones-to Treat or Not to Treat.

Authors:  Necole M Streeper
Journal:  Curr Urol Rep       Date:  2018-03-17       Impact factor: 3.092

2.  Guideline of guidelines for kidney and bladder stones.

Authors:  Thomas Hughes; Hui Ching Ho; Amelia Pietropaolo; Bhaskar K Somani
Journal:  Turk J Urol       Date:  2020-10-09

3.  Evaluating Natural History and Follow Up Strategies for Non-obstructive Urolithiasis in Pediatric Population.

Authors:  Kunj R Sheth; Jeffrey T White; Andre F Perez-Orozco; Natalie D Debolske; Christopher R Hyde; Christine Geistkemper; David R Roth; Paul F Austin; Edmond T Gonzales; Nicolette K Janzen; Duong D Tu; Angela G Mittal; Chester J Koh; Sheila L Ryan; Carolina Jorgez; Abhishek Seth
Journal:  Front Pediatr       Date:  2018-11-16       Impact factor: 3.418

4.  Effect of Polycitra-K and Bicitra in the Treatment of Pediatric Nephrolithiasis: A Double-Blind Randomized Trial.

Authors:  Mohammad Reza Razavi; Mostafa Vahedian; Fereshteh Motharinejad; Hojatollah Jafari; Mohsen A Khavan Sepahi
Journal:  Med J Islam Repub Iran       Date:  2022-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.